MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | - | - | - | ₹1.45 Cr | ₹1.45 Cr |
What is the latest Contingent Liabilities ratio of MARKSANS PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | - |
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | ₹1.45 Cr |
| Mar2022 | ₹1.45 Cr |
How is Contingent Liabilities of MARKSANS PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | - | 0 | |
| Mar2025 | - | 0 | |
| Mar2024 | - | -100.00 | |
| Mar2023 | ₹1.45 Cr | 0.00 | |
| Mar2022 | ₹1.45 Cr | - | |
Compare Contingent Liabilities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹14,559.1 Cr | -3.7% | 33.1% | 78.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | -1.2% | -2.2% | 15.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 1% | 16.3% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | 3.2% | -0.8% | 38.6% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.9% | 1.6% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.7% | -0.1% | -6.5% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | -3.7% |
33.1% |
78.1% |
| SENSEX | -0.7% |
0.1% |
-3.4% |
You may also like the below Video Courses